v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   149,853,135      
Beginning balance at Dec. 31, 2024 $ 1,288,353 $ 15 $ 2,535,868 $ (2,737) $ (1,244,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   149,650      
Exercise of stock options 2,352   2,352    
Stock-based compensation 52,402   52,402    
Issuance of common stock upon settlement of restricted stock units (in shares)   882,979      
Shares withheld related to net share settlement of equity awards (in shares)   (331,056)      
Shares withheld related to net share settlement of equity awards (28,277)   (28,277)    
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)   (1,450,591)      
Repurchase and retirement of common stock, including transaction costs and excise tax (100,440)   (100,440)    
Other comprehensive income (loss) 246     246  
Net income (loss) (32,989)       (32,989)
Ending balance (in shares) at Mar. 31, 2025   149,104,117      
Ending balance at Mar. 31, 2025 1,181,647 $ 15 2,461,905 (2,491) (1,277,782)
Beginning balance (in shares) at Dec. 31, 2024   149,853,135      
Beginning balance at Dec. 31, 2024 1,288,353 $ 15 2,535,868 (2,737) (1,244,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (54,078)        
Ending balance (in shares) at Jun. 30, 2025   150,189,021      
Ending balance at Jun. 30, 2025 1,217,599 $ 15 2,517,880 (1,425) (1,298,871)
Beginning balance (in shares) at Mar. 31, 2025   149,104,117      
Beginning balance at Mar. 31, 2025 1,181,647 $ 15 2,461,905 (2,491) (1,277,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   335,896      
Exercise of stock options 5,218   5,218    
Stock-based compensation 60,651   60,651    
Issuance of common stock upon settlement of restricted stock units (in shares)   865,285      
Issuance of common stock for employee stock purchase plan (in shares)   245,276      
Issuance of common stock for employee stock purchase plan 14,404   14,404    
Shares withheld related to net share settlement of equity awards (in shares)   (313,050)      
Shares withheld related to net share settlement of equity awards (21,577)   (21,577)    
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)   (48,503)      
Repurchase and retirement of common stock, including transaction costs and excise tax (2,721)   (2,721)    
Other comprehensive income (loss) 1,066     1,066  
Net income (loss) (21,089)       (21,089)
Ending balance (in shares) at Jun. 30, 2025   150,189,021      
Ending balance at Jun. 30, 2025 1,217,599 $ 15 2,517,880 (1,425) (1,298,871)
Beginning balance (in shares) at Dec. 31, 2025   151,708,564      
Beginning balance at Dec. 31, 2025 1,262,262 $ 15 2,609,093 (1,270) (1,345,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   277,900      
Exercise of stock options 2,503   2,503    
Stock-based compensation 61,337   61,337    
Issuance of common stock upon settlement of restricted stock units (in shares)   821,336      
Shares withheld related to net share settlement of equity awards (in shares)   (294,608)      
Shares withheld related to net share settlement of equity awards (15,291)   (15,291)    
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)   (1,765,560)      
Repurchase and retirement of common stock, including transaction costs and excise tax (100,615)   (100,615)    
Other comprehensive income (loss) (723)     (723)  
Net income (loss) (9,096)       (9,096)
Ending balance (in shares) at Mar. 31, 2026   150,747,632      
Ending balance at Mar. 31, 2026 1,200,377 $ 15 2,557,027 (1,993) (1,354,672)
Beginning balance (in shares) at Dec. 31, 2025   151,708,564      
Beginning balance at Dec. 31, 2025 $ 1,262,262 $ 15 2,609,093 (1,270) (1,345,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 531,931        
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares) (1,765,560)        
Repurchase and retirement of common stock, including transaction costs and excise tax $ (100,000)        
Net income (loss) 7,826        
Ending balance (in shares) at Jun. 30, 2026   151,885,923      
Ending balance at Jun. 30, 2026 1,278,450 $ 15 2,618,652 (2,467) (1,337,750)
Beginning balance (in shares) at Mar. 31, 2026   150,747,632      
Beginning balance at Mar. 31, 2026 1,200,377 $ 15 2,557,027 (1,993) (1,354,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   254,031      
Exercise of stock options 1,913   1,913    
Stock-based compensation 61,554   61,554    
Issuance of common stock upon settlement of restricted stock units (in shares)   871,731      
Issuance of common stock for employee stock purchase plan (in shares)   330,571      
Issuance of common stock for employee stock purchase plan 13,007   13,007    
Shares withheld related to net share settlement of equity awards (in shares)   (318,042)      
Shares withheld related to net share settlement of equity awards (15,222)   (15,222)    
Repurchase and retirement of common stock, including transaction costs and excise tax 373   373    
Other comprehensive income (loss) (474)     (474)  
Net income (loss) 16,922       16,922
Ending balance (in shares) at Jun. 30, 2026   151,885,923      
Ending balance at Jun. 30, 2026 $ 1,278,450 $ 15 $ 2,618,652 $ (2,467) $ (1,337,750)